Savara
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
CEOMatthew Pauls
CEOMatthew Pauls
Employees37
Employees37
HeadquartersLanghorne, Pennsylvania
HeadquartersLanghorne, Pennsylvania
Founded1995
Founded1995
Employees37
Employees37
SVRA Key Statistics
Market cap687.98M
Market cap687.98M
Price-Earnings ratio-14.89
Price-Earnings ratio-14.89
Dividend yield—
Dividend yield—
Average volume570.19K
Average volume570.19K
High today$5.03
High today$5.03
Low today$4.85
Low today$4.85
Open price$4.88
Open price$4.88
Volume904.12K
Volume904.12K
52 Week high$5.70
52 Week high$5.70
52 Week low$1.63
52 Week low$1.63
SVRA News
Yahoo Finance 7d
Savara Announces New Employment Inducement Grant - Yahoo FinanceAUSTIN, Texas, March 22, 2024--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, tod...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%